Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bicarbonate SCHEMBL11311527 | 0.90 | AKR1B1 (0.46) | LMNAAKR1B1TSHRSLC6A2SLC6A4 | |
| Acetic Acid SCHEMBL11281238 | 0.85 | AKR1B1 (0.48) | LMNAAKR1B1TSHRSLC6A2SLC6A4 | |
| Acetic Acid SCHEMBL7700165 | 0.85 | AKR1B1 (0.48) | LMNAAKR1B1TSHRSLC6A2SLC6A4 | |
| SCHEMBL93405 | 0.84 | — | — | |
| SCHEMBL4263981 | 0.84 | — | — | |
| SCHEMBL284308 | 0.84 | — | — | |
| Acrylic Acid SCHEMBL3151093 | 0.81 | LMNA (0.59) | LMNAAKR1B1ALOX15HSD17B10TSHR | |
| Thioglycolic Acid SCHEMBL27553790 | 0.81 | SLC6A2 (0.39) | AKR1B1TSHRSLC6A2SLC6A4BLM | |
| Propionic Acid SCHEMBL9690988 | 0.81 | FFAR3 (0.46) | AKR1B1ALOX15HSD17B10TSHRSLC6A2 | |
| Methacrylic Acid SCHEMBL27592212 | 0.79 | TGFBR1 (0.38) | LMNAAKR1B1ALOX15HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2598101-B2 | KIT OF PARTS, METHOD OF PRODUCING AND USE THEREOF | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY (US) | 2024-08-14 | — | — | EP | disclosed |
| US-11510851-B2 | Application device with redox initiator system, method of production and use thereof | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-11-29 | — | — | US | disclosed |
| EP-4072686-A1 | ORAL CARE COMPOSITION WITH N-ACETYL AMINO ACID COMPONENTS FOR TREATING CARIES | 3M Innovative Properties Company (US) | 2022-10-19 | — | — | EP | disclosed |
| EP-4065067-A1 | ORAL CARE COMPOSITION WITH CHOLIC ACID COMPONENTS FOR TREATING CARIES | 3M Innovative Properties Company (US) | 2022-10-05 | — | — | EP | disclosed |
| EP-4034077-A1 | ORAL CARE COMPOSITION WITH AMMONIUM ALKYL SULFONATE OR CARBONATE COMPONENTS FOR TREATING CARIES | 3M Innovative Properties Company (US) | 2022-08-03 | — | — | EP | disclosed |
| EP-3962444-A1 | QUATERNARY AMMONIUM ALKYL COMPONENT CONTAINING ORAL CARE COMPOSITION FOR TREATING CARIES | 3M Innovative Properties Company (US) | 2022-03-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11510851-B2 | Application device with redox initiator system, method of production and use thereof | PRDX3, GFER, GPX4 | LMNA 3724/4885AKR1B1 173/4885ALOX15 392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.